Toshiro Kendrick Ohsumi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sequence Analysis | 1 | 2012 | 256 | 0.400 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 2015 | 546 | 0.390 |
Why?
|
| Computational Biology | 3 | 2013 | 3518 | 0.200 |
Why?
|
| Genome | 4 | 2014 | 1803 | 0.190 |
Why?
|
| T-Lymphocytes | 5 | 2016 | 10163 | 0.160 |
Why?
|
| Collagen | 1 | 2007 | 2684 | 0.160 |
Why?
|
| Software | 1 | 2012 | 4434 | 0.160 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.140 |
Why?
|
| Oral Ulcer | 1 | 2017 | 96 | 0.140 |
Why?
|
| Skin Ulcer | 1 | 2017 | 118 | 0.140 |
Why?
|
| Gene Rearrangement | 2 | 2012 | 1179 | 0.140 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 275 | 0.140 |
Why?
|
| RNA, Small Interfering | 4 | 2014 | 3504 | 0.130 |
Why?
|
| Endodeoxyribonucleases | 1 | 2016 | 162 | 0.130 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 329 | 0.130 |
Why?
|
| B-Lymphocytes | 4 | 2016 | 4664 | 0.130 |
Why?
|
| Chromosome Breakage | 2 | 2012 | 173 | 0.130 |
Why?
|
| Biological Therapy | 1 | 2016 | 138 | 0.120 |
Why?
|
| Genes, Dominant | 1 | 2017 | 880 | 0.120 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2417 | 0.120 |
Why?
|
| Receptors, Transferrin | 1 | 2015 | 296 | 0.120 |
Why?
|
| Homozygote | 2 | 2015 | 1777 | 0.120 |
Why?
|
| Pedigree | 6 | 2017 | 4646 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 6 | 2017 | 4801 | 0.110 |
Why?
|
| Agammaglobulinemia | 1 | 2014 | 167 | 0.110 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 905 | 0.100 |
Why?
|
| Programming Languages | 1 | 2012 | 134 | 0.100 |
Why?
|
| Mutation | 6 | 2015 | 29717 | 0.100 |
Why?
|
| Calcium Channels | 1 | 2015 | 621 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 581 | 0.100 |
Why?
|
| Eukaryota | 1 | 2012 | 100 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 375 | 0.100 |
Why?
|
| Xenopus | 2 | 2011 | 712 | 0.100 |
Why?
|
| Fibroblasts | 3 | 2017 | 4143 | 0.100 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2013 | 221 | 0.100 |
Why?
|
| X Chromosome Inactivation | 1 | 2012 | 224 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2015 | 1185 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2015 | 971 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 587 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1152 | 0.090 |
Why?
|
| Germ Cells | 1 | 2014 | 628 | 0.090 |
Why?
|
| Caspases | 1 | 2013 | 928 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 814 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2015 | 710 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1520 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 748 | 0.080 |
Why?
|
| Clostridium Infections | 1 | 2016 | 548 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2011 | 1086 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 623 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 457 | 0.080 |
Why?
|
| Ovum | 1 | 2009 | 189 | 0.080 |
Why?
|
| Killer Cells, Natural | 2 | 2015 | 2133 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 2 | 2013 | 2011 | 0.080 |
Why?
|
| Arginine | 1 | 2012 | 944 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 4187 | 0.080 |
Why?
|
| RNA Interference | 2 | 2014 | 2890 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2915 | 0.080 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2014 | 849 | 0.070 |
Why?
|
| Lysine | 1 | 2012 | 1008 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 615 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2556 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2013 | 795 | 0.070 |
Why?
|
| Microtubules | 1 | 2011 | 1090 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2013 | 1707 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1811 | 0.070 |
Why?
|
| Microglia | 1 | 2013 | 1261 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2015 | 4024 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 1416 | 0.060 |
Why?
|
| Base Sequence | 5 | 2017 | 12797 | 0.060 |
Why?
|
| Finite Element Analysis | 1 | 2007 | 431 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 2130 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 1786 | 0.060 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 1465 | 0.060 |
Why?
|
| Genome, Human | 2 | 2012 | 4420 | 0.050 |
Why?
|
| Histones | 1 | 2012 | 2597 | 0.050 |
Why?
|
| Chromatin | 1 | 2013 | 2917 | 0.050 |
Why?
|
| Chromosome Inversion | 2 | 2012 | 127 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 2986 | 0.050 |
Why?
|
| DNA Barcoding, Taxonomic | 2 | 2013 | 136 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2021 | 184 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3691 | 0.050 |
Why?
|
| RNA | 1 | 2010 | 2747 | 0.050 |
Why?
|
| Animals | 15 | 2017 | 168561 | 0.050 |
Why?
|
| Neoplasms | 3 | 2021 | 21596 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2015 | 1849 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2013 | 13029 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2010 | 3020 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2014 | 2257 | 0.040 |
Why?
|
| Diarrhea | 2 | 2016 | 1343 | 0.040 |
Why?
|
| Heart Valve Prosthesis | 1 | 2007 | 1486 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5163 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 4328 | 0.040 |
Why?
|
| Xenopus Proteins | 2 | 2011 | 433 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 695 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 17400 | 0.040 |
Why?
|
| Autoantibodies | 2 | 2016 | 2036 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2012 | 7716 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2017 | 236 | 0.040 |
Why?
|
| Poly I-C | 1 | 2016 | 115 | 0.040 |
Why?
|
| Genomics | 1 | 2012 | 5692 | 0.030 |
Why?
|
| Translocation, Genetic | 2 | 2012 | 1417 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 18112 | 0.030 |
Why?
|
| Warts | 1 | 2015 | 68 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2017 | 19223 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2015 | 287 | 0.030 |
Why?
|
| Fluoroimmunoassay | 1 | 2014 | 33 | 0.030 |
Why?
|
| Mice | 7 | 2016 | 81045 | 0.030 |
Why?
|
| Algorithms | 2 | 2012 | 13853 | 0.030 |
Why?
|
| DNA | 2 | 2021 | 7289 | 0.030 |
Why?
|
| Ion Transport | 1 | 2015 | 320 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2015 | 236 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2015 | 821 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2015 | 399 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 424 | 0.030 |
Why?
|
| Consanguinity | 1 | 2015 | 456 | 0.030 |
Why?
|
| Humans | 19 | 2023 | 742088 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 792 | 0.030 |
Why?
|
| Lymphopenia | 1 | 2015 | 285 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3920 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 2013 | 251 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2015 | 642 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 5851 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1866 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2014 | 608 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3444 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2015 | 880 | 0.030 |
Why?
|
| Immune System Diseases | 1 | 2014 | 262 | 0.030 |
Why?
|
| Receptors, Antigen | 1 | 2012 | 53 | 0.030 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 251 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2014 | 2749 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 497 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14554 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2015 | 40955 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 749 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2011 | 49 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2014 | 389 | 0.020 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2011 | 54 | 0.020 |
Why?
|
| Siblings | 1 | 2015 | 854 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 983 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2014 | 370 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 712 | 0.020 |
Why?
|
| Male | 10 | 2017 | 349538 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 799 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 655 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2016 | 3127 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 474 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 1988 | 0.020 |
Why?
|
| Female | 10 | 2017 | 379592 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 892 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1184 | 0.020 |
Why?
|
| Colitis | 1 | 2017 | 1149 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Methylation | 1 | 2012 | 1107 | 0.020 |
Why?
|
| Karyotyping | 1 | 2011 | 1243 | 0.020 |
Why?
|
| Oogenesis | 1 | 2009 | 131 | 0.020 |
Why?
|
| X Chromosome | 1 | 2012 | 815 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 553 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2017 | 2500 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2012 | 1202 | 0.020 |
Why?
|
| Gene Library | 1 | 2011 | 1076 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9410 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2021 | 5019 | 0.020 |
Why?
|
| Actins | 1 | 2015 | 2120 | 0.020 |
Why?
|
| Tubulin | 1 | 2011 | 695 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2008 | 211 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 670 | 0.020 |
Why?
|
| Meiosis | 1 | 2009 | 338 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1400 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 5892 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 1546 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2015 | 1065 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 1586 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 21821 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 3293 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 730 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 1208 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2203 | 0.020 |
Why?
|
| Anemia | 1 | 2015 | 1499 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4200 | 0.020 |
Why?
|
| Child | 4 | 2015 | 77478 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4414 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 5872 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5180 | 0.020 |
Why?
|
| Oocytes | 1 | 2009 | 1186 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 9639 | 0.010 |
Why?
|
| Cell Division | 1 | 2011 | 4564 | 0.010 |
Why?
|
| Hospitalization | 1 | 2023 | 10232 | 0.010 |
Why?
|
| Binding Sites | 1 | 2012 | 6115 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1940 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1294 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2964 | 0.010 |
Why?
|
| Adolescent | 3 | 2016 | 85649 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 1937 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5975 | 0.010 |
Why?
|
| Infant | 2 | 2015 | 35070 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 4379 | 0.010 |
Why?
|
| Autistic Disorder | 1 | 2012 | 1174 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2440 | 0.010 |
Why?
|
| Genome-Wide Association Study | 2 | 2012 | 12220 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2012 | 2572 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 1884 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 5519 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9144 | 0.010 |
Why?
|
| Gene Expression | 1 | 2015 | 7790 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 2126 | 0.010 |
Why?
|
| Drosophila | 1 | 2009 | 1484 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1899 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2014 | 3439 | 0.010 |
Why?
|
| Alleles | 1 | 2012 | 6931 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13814 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12705 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2015 | 23387 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 40450 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 9715 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3336 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 3585 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10472 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 9387 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15994 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 16331 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13256 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 3639 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5425 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 6540 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18355 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 7721 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 16665 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 6096 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15494 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77098 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14720 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2012 | 6874 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 19862 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 12071 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 213712 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 57683 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 56350 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 162944 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 213127 | 0.000 |
Why?
|